Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.70
    0.46 (3.76%)
    At close: Aug 21, 2025, 3:46 PM
    12.70
    0.00%
    After-hours: Aug 21, 2025, 04:00 PM EDT

    Innovent Biologics Balance Sheet Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.51B 10.05B 1.02B 1.36B
    Short-Term Investments
    		 375.56M 917.53M 7.25B 6.58B
    Long-Term Investments
    		 3.63B 794.09M 713.22M -6.16B
    Other Long-Term Assets
    		 774.02M 1.72B 110.04M 6.71B
    Receivables
    		 1.57B 1.01B 575.27M 968.4M
    Inventory
    		 822.17M 968.09M 1.43B 1.35B
    Other Current Assets
    		 n/a 484.38M 336.52M 219.9M
    Total Current Assets
    		 10.27B 13.43B 11.51B 11.55B
    Property-Plant & Equipment
    		 5.65B 4.66B 4.06B 3.38B
    Goodwill & Intangibles
    		 1.28B 27.79M 1.2B 772.19M
    Total Long-Term Assets
    		 11.33B 7.2B 6.08B 4.69B
    Total Assets
    		 21.6B 20.63B 17.59B 16.24B
    Account Payables
    		 357.68M 372.55M 325.62M 195.05M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 405.1M 1.2B 888M 365M
    Other Current Liabilities
    		 2.32B 728.33M 741.92M 790.15M
    Total Current Liabilities
    		 4.37B 4.48B 3.5B 3.05B
    Long-Term Debt
    		 2.41B 2.33B 2.22B 2.02B
    Other Long-Term Liabilities
    		 1.7B 1.22B 1.05B 753.62M
    Total Long-Term Liabilities
    		 4.12B 3.62B 3.36B 2.86B
    Total Liabilities
    		 8.48B 8.1B 6.86B 5.91B
    Total Debt
    		 2.83B 3.62B 3.23B 2.5B
    Common Stock
    		 113K 112K 105K 101K
    Retained Earnings
    		 n/a -15.77B -16.68B -12.56B
    Comprehensive Income
    		 n/a n/a 763.86M 397.02M
    Shareholders Equity
    		 13.12B 12.53B 10.73B 10.33B
    Total Investments
    		 3.9B 794.09M 630.2M 417.25M

    Add to Watchlist